Browse: Authors | Keywords | All Center-Authored Publications
Filter by Division: Basic | Clinical | Human Biology | PHS | VIDD (2010-present) | VIDI (2008-2009)
Filter by Year: 2008 | 2009 | 2010 | 2011 | 2012 | 2013
Filters: Author is Barlow, William E [Clear All Filters]
Results from a randomized trial of a web-based, tailored decision aid for women at high risk for breast cancer.. Patient education and counseling. 91(3):364-71.. 2013.
Does surgeon case volume influence nonfatal adverse outcomes after rectal cancer resection? Journal of the American College of Surgeons. 206(3):1167-77.. 2008.
A phase II study of imatinib mesylate and capecitabine in metastatic breast cancer: Southwest Oncology Group Study 0338.. Clinical breast cancer. 8(6):511-5.. 2008.
Tumor metabolism and blood flow changes by positron emission tomography: relation to survival in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(27):4449-57.. 2008.
Multiplexed assessment of the Southwest Oncology Group-directed Intergroup Breast Cancer Trial S9313 by AQUA shows that both high and low levels of HER2 are associated with poor outcome.. The American journal of pathology. 176(4):1639-47.. 2010.
Measuring the performance of markers for guiding treatment decisions.. Annals of internal medicine. 154(4):253-9.. 2011.
Combination anastrozole and fulvestrant in metastatic breast cancer.. The New England journal of medicine. 367(5):435-44.. 2012.
Contrasting two frameworks for ROC analysis of ordinal ratings.. Medical decision making : an international journal of the Society for Medical Decision Making. 30(4):484-98.. 2010.
Reproductive history and risk of three breast cancer subtypes defined by three biomarkers.. Cancer causes & control : CCC. 22(3):399-405.. 2011.
Breast Density, Body Mass Index, and Risk of Tumor Marker-Defined Subtypes of Breast Cancer.. Annals of epidemiology. 22(5):340-348.. 2012.
Family history of breast cancer in first-degree relatives and triple-negative breast cancer risk.. Breast cancer research and treatment. 126(3):671-8.. 2011.
Risk factors for ductal, lobular, and mixed ductal-lobular breast cancer in a screening population.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 19(6):1643-54.. 2010.
Outcome of patients with early-stage breast cancer treated with doxorubicin-based adjuvant chemotherapy as a function of HER2 and TOP2A status.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(24):3881-6.. 2009.
Identifying Persons at Highest Risk of Melanoma Using Self-Assessed Risk Factors.. Journal of clinical & experimental dermatology research. 2(6). 2011.
Frequent antibiotic use and second breast cancer events.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 22(9):1588-99.. 2013.
The value of comparative effectiveness research: Projected return on investment of the RxPONDER trial (SWOG S1007).. Contemporary clinical trials. 33(6):1117-23.. 2012.
Doing Business with Arnold Library
Weintraub Building, B1-010
More About Arnold Library
- Information for Grant Writers
- Arnold Library News
- Affiliations and Memberships
- Journals List
- Web of Science - Science Citation Index
- Pubmed (Get Article Enabled)
- Library Catalog
- Document Delivery Form
- Center-Authored Papers
- Institutional Repository
- Researcher Profiles